SLRC:NASDAQSLR Investment Corp. Analysis
Data as of 2026-05-01 - not real-time
$15.80
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
SLR Investment Corp. trades at a trailing PE of 9.3, well below the industry average of 17.6, and a price‑to‑book of 0.86, suggesting a materially undervalued position. The stock offers an eye‑catching dividend yield of 10.4% but the payout ratio of 96% coupled with negative operating cash flow raises concerns about sustainability, especially given a high debt‑to‑equity of 115. Nonetheless, the balance sheet holds ample cash (~$364 M) and free cash flow is modestly positive, while revenue is flat and margins remain strong, supporting the current valuation.
Technical signals are mixed: the price of $15.80 sits above the 20‑day SMA (15.46) and the 200‑day SMA (15.40) but the MACD histogram is negative and the MACD line sits below its signal, hinting at short‑term bearish pressure. The RSI at 59 indicates no immediate overbought condition, and the stock trades within a support zone near $14.06 and a resistance near $16.36. Volatility is elevated at ~24.8% over 30 days, while beta of 0.77 points to lower market sensitivity, framing a moderate risk profile.
Technical signals are mixed: the price of $15.80 sits above the 20‑day SMA (15.46) and the 200‑day SMA (15.40) but the MACD histogram is negative and the MACD line sits below its signal, hinting at short‑term bearish pressure. The RSI at 59 indicates no immediate overbought condition, and the stock trades within a support zone near $14.06 and a resistance near $16.36. Volatility is elevated at ~24.8% over 30 days, while beta of 0.77 points to lower market sensitivity, framing a moderate risk profile.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- High dividend yield but sustainability concerns
- Bearish MACD momentum
- Valuation already reflects discount
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued valuation relative to peers
- Strong asset base and modest free cash flow
- Potential upside above current resistance level
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Elevated leverage and high payout ratio
- Sector cyclicality and interest‑rate sensitivity
- Sustainable cash generation remains uncertain
Key Metrics & Analysis
Financial Health
Revenue Growth-2.00%
Profit Margin42.34%
P/E Ratio9.3
ROE9.30%
ROA3.85%
Debt/Equity115.10
P/B Ratio0.9
Op. Cash Flow$-72022000
Free Cash Flow$6.5M
Industry P/E17.6
Technical Analysis
TrendNeutral
RSI59.2
Support$14.06
Resistance$16.36
MA 20$15.46
MA 50$14.84
MA 200$15.40
MACDBearish
VolumeIncreasing
Fear & Greed Index90.91
Valuation
Target Price$15.83
Upside/Downside0.21%
GradeUndervalued
TypeValue
Dividend Yield10.41%
Risk Assessment
Beta0.77
Volatility24.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.